Nuvation Bio (NUVB) Stock Price, Quote, News & History | Benzinga

Nuvation Bio Inc (NUVB) Stock Price, Quote, News & History

NUVBNYSE

Trade with Public

Trade with Public

$7.10

-0.16-2.2%

Last update: Aug 21, 9:18 AM

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

-

Close

$6.83

Volume / Avg.

61.21K / 6.71M

Day Range

- - -

52 Wk Range

2.57 - 9.75

Market Cap

$2.49B

P/E Ratio

-

Dividend Yield

-

Exchange

NYSE

RSI

60

Short Interest

25.06%

Days to Cover

8.7

Recent Nuvation Bio Inc. News

This Nvidia Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Top Wall Street analysts changed outlook on top names. See all changes on analyst ratings page. AVGO receives Outperform rating with $455 PT.

Avi Kapoor

Why Is Nuvation Bio Stock Gaining Monday?

Nuvation Bio reports positive long-term Phase 2 safusidenib data for glioma patients and expands its clinical trial pipeline.

Vandana Singh

AMC Entertainment, IREN, Hut 8 And Other Big Stocks Moving Higher On Monday

U.S. stocks saw mixed results, with Nasdaq up 150 points. AMC shares rose after beating earnings expectations. Other big gainers include NUAI, IREN, XNCR, HUT, CIFR, CLSK, NUVB, AXTI, ATEX, APLD, and CHRN.

Avi Kapoor

H.B. Fuller, Trip.com, Hertz Global And Other Big Stocks Moving Lower In Thursday Pre-Market Session

U.S. stock futures up, Nasdaq 100 futures gain 2%. H.B. Fuller shares dip 8.3% on earnings release and offer to acquire Advanced Medical Solutions.

Avi Kapoor

MongoDB, Surgery Partners, Harrow And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

MDB stock fell 27.2% in pre-market trading after reporting Q4 earnings of $1.65 per share, revenue of $695.07M, and Q1 guidance below estimates.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-120.52M

Investing Cash Flow (TTM)

-47.18M

Financing Cash Flow (TTM)

179.14M

Free Cash Flow (TTM)

-128.93M

Capital Expenditure (TTM)

-8.40M

Net Change in Cash (TTM)

11.43M

Analyst Trends and Forecast

2

1

Mar

2

Apr

3

May

4

Jul

3

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$1.99B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

13.90

PB Ratio (TTM)

9.45

Earnings Yield % (TTM)

-6.44%

Earnings Yield % (FWD)

-5.64%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.72

Company Debt

Total Debt

$248.52M

LT Debt

$242.62M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$258.60M

Debt to Equity

0.99

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-$69.89M

Key Statistics

Open

-

Close

$6.83

Volume / Avg.

61.21K / 6.71M

Day Range

- - -

52 Wk Range

2.57 - 9.75

Market Cap

$2.49B

P/E Ratio

-

Dividend Yield

-

Exchange

NYSE

RSI

60

Short Interest

25.06%

Days to Cover

8.7

About

Sector

Health Care

Industry

Pharmaceuticals

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-g...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Nuvation Bio (NUVB) stock?

A

You can purchase shares of Nuvation Bio (NYSE:NUVB) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Nuvation Bio (NUVB) competitors?

A

Other companies in Nuvation Bio’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).

Q

What is the forecast, or price target, for Nuvation Bio (NUVB) stock?

A

Nuvation Bio has a consensus price target of $10.87.

Q

What is the current price for Nuvation Bio (NUVB)?

A

The stock price for Nuvation Bio (NYSE: NUVB) is $7.1 last updated August 21, 2026 at 9:18 AM EDT.

Q

Does Nuvation Bio (NUVB) pay a dividend?

A

There are no upcoming dividends for Nuvation Bio.

Q

When is Nuvation Bio (NYSE:NUVB) reporting earnings?

A

Nuvation Bio does not have any upcoming earnings scheduled.

Q

Is Nuvation Bio (NUVB) going to split?

A

There is no upcoming split for Nuvation Bio.

Q

What sector and industry does Nuvation Bio (NUVB) operate in?

A

Nuvation Bio is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.